NRF1 and nasopharyngeal carcinoma: Serum from nasopharyngeal carcinoma patients showed that miR-504 was up-regulated during different weeks of radiotherapy and correlated with tumour volume, lymph nodes, and metastasis stages, demonstrating that miR-504 regulated radioresistance by down-regulating the expression of NRF1 [117].